Grošelj, U., Tanšek, M. Ž., Podkrajšek, K. T., Hovnik, T., Battelino, T., & Dolžan, V. (2016). Clinical Role of CYP2C19 Polymorphisms in Patients with Congenital Adrenal Hyperplasia Due to 21-hydroxylase Deficiency. Acta Chimica Slovenica, 63(1), 33. https://doi.org/10.17344/acsi.2015.1797
Chicago Style (17th ed.) CitationGrošelj, Urh, Mojca Žerjav Tanšek, Katarina Trebušak Podkrajšek, Tinka Hovnik, Tadej Battelino, and Vita Dolžan. "Clinical Role of CYP2C19 Polymorphisms in Patients with Congenital Adrenal Hyperplasia Due to 21-hydroxylase Deficiency." Acta Chimica Slovenica 63, no. 1 (2016): 33. https://doi.org/10.17344/acsi.2015.1797.
MLA (9th ed.) CitationGrošelj, Urh, et al. "Clinical Role of CYP2C19 Polymorphisms in Patients with Congenital Adrenal Hyperplasia Due to 21-hydroxylase Deficiency." Acta Chimica Slovenica, vol. 63, no. 1, 2016, p. 33, https://doi.org/10.17344/acsi.2015.1797.